Skip to main content
Top
Published in: Infection 5/2012

01-10-2012 | Clinical and Epidemiological Study

Clinical benefit of infectious diseases consultation: a monocentric prospective cohort study

Authors: A. de La Blanchardière, J. Boutemy, P. Thibon, J. Michon, R. Verdon, V. Cattoir

Published in: Infection | Issue 5/2012

Login to get access

Abstract

Purpose

To determine the association of clinical outcomes with the adherence to Infectious Diseases Consultation (IDC) recommendations.

Methods

From March to August 2009, all patients hospitalized in our hospital, for whom an IDC was requested, were prospectively enrolled. The adherence to recommendations was ascertained after 72 h from the IDC. The primary objective of the study was to evaluate the clinical cure rate 1 month after the IDC, according to the adherence to IDC recommendations.

Results

An IDC was requested for 258 inpatients. The infectious disease (ID) was most often non-severe (66 %), community-acquired (62 %), and already under treatment (47 %). IDC proposals were most often formulated via a formal consultation (57 %). Physicians’ adherence to IDC recommendations was 87 % for diagnostic tests and 90 % for antibiotherapy. In the multivariate analysis, severe infections and direct consultation were independently associated with increased odds of adherence to recommendations for performing diagnostic tests (odds ratios 5.4 and 4.0, respectively). The overall clinical cure rate was 84 % and this did not differ according to the adherence to IDC recommendations for diagnostic tests (84.3 vs. 71.4 %, p = 0.15) and antimicrobial treatment (84.8 vs. 77.8 %, p = 0.34).

Conclusions

Some limitations of the study may explain the lack of evidence of a clinical benefit, such as the very high level of adherence to IDC recommendations and the low proportion of severe infections. However, clinical improvement was always better when recommendations were followed. Therefore, further larger randomized multicentric studies including more patients suffering from more severe IDs may be needed in order to demonstrate a clinical impact.
Literature
1.
go back to reference Sarkar P, Gould IM. Antimicrobial agents are societal drugs: how should this influence prescribing? Drugs. 2006;66:893–901.PubMedCrossRef Sarkar P, Gould IM. Antimicrobial agents are societal drugs: how should this influence prescribing? Drugs. 2006;66:893–901.PubMedCrossRef
2.
3.
go back to reference Roberts AW, Visconti JA. The rational and irrational use of systemic antimicrobial drugs. Am J Hosp Pharm. 1972;29:828–34.PubMed Roberts AW, Visconti JA. The rational and irrational use of systemic antimicrobial drugs. Am J Hosp Pharm. 1972;29:828–34.PubMed
4.
go back to reference Reimann HA. The misuse of antimicrobics. Med Clin North Am. 1961;45:849–56.PubMed Reimann HA. The misuse of antimicrobics. Med Clin North Am. 1961;45:849–56.PubMed
5.
go back to reference Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis. 1988;157:869–76.PubMedCrossRef Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis. 1988;157:869–76.PubMedCrossRef
6.
go back to reference Kislak JW, Eickhoff TC, Finland M. Hospital-acquired infections and antibiotic usage in the Boston city hospital—January, 1964. N Eng J Med. 1964;271:834–5.CrossRef Kislak JW, Eickhoff TC, Finland M. Hospital-acquired infections and antibiotic usage in the Boston city hospital—January, 1964. N Eng J Med. 1964;271:834–5.CrossRef
7.
go back to reference John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997;24:471–85.PubMedCrossRef John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997;24:471–85.PubMedCrossRef
8.
go back to reference Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42:S82–9.PubMedCrossRef Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42:S82–9.PubMedCrossRef
9.
go back to reference Roberts RR, Hota B, Ahmad I, Scott RD 2nd, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009;49:1175–84.PubMedCrossRef Roberts RR, Hota B, Ahmad I, Scott RD 2nd, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009;49:1175–84.PubMedCrossRef
10.
go back to reference Spencer RC. The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease. J Antimicrob Chemother. 1998;41:21–7.PubMedCrossRef Spencer RC. The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease. J Antimicrob Chemother. 1998;41:21–7.PubMedCrossRef
11.
go back to reference Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010;74:309–18.PubMedCrossRef Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010;74:309–18.PubMedCrossRef
12.
go back to reference McFarland LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol. 2008;5:40–8.PubMedCrossRef McFarland LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol. 2008;5:40–8.PubMedCrossRef
13.
go back to reference Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.PubMedCrossRef Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.PubMedCrossRef
14.
go back to reference Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, Holmes A, Ramsay C, Taylor E, Wilcox M, Wiffen P. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2005;(4):CD003543. Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, Holmes A, Ramsay C, Taylor E, Wilcox M, Wiffen P. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2005;(4):CD003543.
15.
go back to reference Patel D, Lawson W, Guglielmo BJ. Antimicrobial stewardship programs: interventions and associated outcomes. Expert Rev Anti Infect Ther. 2008;6:209–22.PubMedCrossRef Patel D, Lawson W, Guglielmo BJ. Antimicrobial stewardship programs: interventions and associated outcomes. Expert Rev Anti Infect Ther. 2008;6:209–22.PubMedCrossRef
16.
go back to reference Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, Gottlieb G, McClelland RS, Corey GR. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis. 1998;27:478–86.PubMedCrossRef Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, Gottlieb G, McClelland RS, Corey GR. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis. 1998;27:478–86.PubMedCrossRef
17.
go back to reference Kim BN. Compliance with an infectious disease specialist’s advisory consultations on targeted antibiotic usage. J Infect Chemother. 2005;11:84–8.PubMedCrossRef Kim BN. Compliance with an infectious disease specialist’s advisory consultations on targeted antibiotic usage. J Infect Chemother. 2005;11:84–8.PubMedCrossRef
18.
go back to reference Lo E, Rezai K, Evans AT, Madariaga MG, Phillips M, Brobbey W, Schwartz DN, Wang Y, Weinstein RA, Trenholme GM. Why don’t they listen? Adherence to recommendations of infectious disease consultations. Clin Infect Dis. 2004;38:1212–8.PubMedCrossRef Lo E, Rezai K, Evans AT, Madariaga MG, Phillips M, Brobbey W, Schwartz DN, Wang Y, Weinstein RA, Trenholme GM. Why don’t they listen? Adherence to recommendations of infectious disease consultations. Clin Infect Dis. 2004;38:1212–8.PubMedCrossRef
19.
go back to reference Gómez J, Conde Cavero SJ, Hernández Cardona JL, Núñez ML, Ruiz Gómez J, Canteras M, Valdés M. The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital. J Antimicrob Chemother. 1996;38:309–14.PubMedCrossRef Gómez J, Conde Cavero SJ, Hernández Cardona JL, Núñez ML, Ruiz Gómez J, Canteras M, Valdés M. The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital. J Antimicrob Chemother. 1996;38:309–14.PubMedCrossRef
20.
go back to reference Méan M, Pavèse P, Tudela E, Dinh-Van KA, Mallaret MR, Stahl JP. Consultations with infectious disease specialists for patients in a teaching hospital: adherence in 174 cases. Presse Med. 2006;35:1461–6.PubMedCrossRef Méan M, Pavèse P, Tudela E, Dinh-Van KA, Mallaret MR, Stahl JP. Consultations with infectious disease specialists for patients in a teaching hospital: adherence in 174 cases. Presse Med. 2006;35:1461–6.PubMedCrossRef
21.
go back to reference Pulcini C, Pradier C, Samat-Long C, Hyvernat H, Bernardin G, Ichai C, Dellamonica P, Roger PM. Factors associated with adherence to infectious diseases advice in two intensive care units. J Antimicrob Chemother. 2006;57:546–50.PubMedCrossRef Pulcini C, Pradier C, Samat-Long C, Hyvernat H, Bernardin G, Ichai C, Dellamonica P, Roger PM. Factors associated with adherence to infectious diseases advice in two intensive care units. J Antimicrob Chemother. 2006;57:546–50.PubMedCrossRef
22.
go back to reference Sellier E, Pavese P, Gennai S, Stahl JP, Labarère J, François P. Factors and outcomes associated with physicians’ adherence to recommendations of infectious disease consultations for inpatients. J Antimicrob Chemother. 2010;65:156–62.PubMedCrossRef Sellier E, Pavese P, Gennai S, Stahl JP, Labarère J, François P. Factors and outcomes associated with physicians’ adherence to recommendations of infectious disease consultations for inpatients. J Antimicrob Chemother. 2010;65:156–62.PubMedCrossRef
23.
go back to reference Sellier E, Labarère J, Gennai S, Bal G, François P, Pavese P. Compliance with recommendations and clinical outcomes for formal and informal infectious disease specialist consultations. Eur J Clinical Microbiol Infect Dis. 2011;30:887–94.CrossRef Sellier E, Labarère J, Gennai S, Bal G, François P, Pavese P. Compliance with recommendations and clinical outcomes for formal and informal infectious disease specialist consultations. Eur J Clinical Microbiol Infect Dis. 2011;30:887–94.CrossRef
24.
go back to reference Gennai S, François P, Bal G, Epaulard O, Stahl JP, Vittoz JP, Pavese P. Evaluation of a remote infectious disease consultation. Med Mal Infect. 2009;39:798–805.PubMedCrossRef Gennai S, François P, Bal G, Epaulard O, Stahl JP, Vittoz JP, Pavese P. Evaluation of a remote infectious disease consultation. Med Mal Infect. 2009;39:798–805.PubMedCrossRef
25.
go back to reference Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS. Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med. 1997;157:1689–94.PubMedCrossRef Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS. Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med. 1997;157:1689–94.PubMedCrossRef
26.
go back to reference Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med. 2010;123:631–7.PubMedCrossRef Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med. 2010;123:631–7.PubMedCrossRef
27.
go back to reference Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46:1000–8.PubMedCrossRef Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46:1000–8.PubMedCrossRef
28.
go back to reference Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A, Thys JP. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis. 1999;29:60–6.PubMedCrossRef Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A, Thys JP. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis. 1999;29:60–6.PubMedCrossRef
29.
go back to reference Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF Jr, Lloyd JF, Burke JP. A computer-assisted management program for antibiotics and other antiinfective agents. N Eng J Med. 1998;338:232–8.CrossRef Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF Jr, Lloyd JF, Burke JP. A computer-assisted management program for antibiotics and other antiinfective agents. N Eng J Med. 1998;338:232–8.CrossRef
30.
go back to reference Taur Y, Smith MA. Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection. Clin Infect Dis. 2007;44:769–74.PubMedCrossRef Taur Y, Smith MA. Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection. Clin Infect Dis. 2007;44:769–74.PubMedCrossRef
31.
go back to reference Girotti MJ, Fodoruk S, Irvine-Meek J, Rotstein OD. Antibiotic handbook and pre-printed perioperative order forms for surgical antibiotic prophylaxis: do they work? Can J Surg. 1990;33:385–8.PubMed Girotti MJ, Fodoruk S, Irvine-Meek J, Rotstein OD. Antibiotic handbook and pre-printed perioperative order forms for surgical antibiotic prophylaxis: do they work? Can J Surg. 1990;33:385–8.PubMed
32.
go back to reference MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18:638–56.PubMedCrossRef MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18:638–56.PubMedCrossRef
33.
go back to reference Mol PGM, Wieringa JE, NannanPanday PV, Gans ROB, Degener JE, Laseur M, Haaijer-Ruskamp FM. Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis. J Antimicrob Chemother. 2005;55:550–7.PubMedCrossRef Mol PGM, Wieringa JE, NannanPanday PV, Gans ROB, Degener JE, Laseur M, Haaijer-Ruskamp FM. Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis. J Antimicrob Chemother. 2005;55:550–7.PubMedCrossRef
34.
go back to reference Linkin DR, Paris S, Fishman NO, Metlay JP, Lautenbach E. Inaccurate communications in telephone calls to an antimicrobial stewardship program. Infect Control Hosp Epidemiol. 2006;27:688–94.PubMedCrossRef Linkin DR, Paris S, Fishman NO, Metlay JP, Lautenbach E. Inaccurate communications in telephone calls to an antimicrobial stewardship program. Infect Control Hosp Epidemiol. 2006;27:688–94.PubMedCrossRef
Metadata
Title
Clinical benefit of infectious diseases consultation: a monocentric prospective cohort study
Authors
A. de La Blanchardière
J. Boutemy
P. Thibon
J. Michon
R. Verdon
V. Cattoir
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Infection / Issue 5/2012
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0283-0

Other articles of this Issue 5/2012

Infection 5/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.